In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EDAP International

This article was originally published in The Gray Sheet

Executive Summary

Acquires "certain assets" of Technomed International including exclusive U.S. distribution rights for Technomed's Sonolith lithotripter, Pulsolith laser lithotripter and Prostatron thermal therapy device. Earlier this year, EDAP's French parent company, EDAP International SA, "purchased the licenses, patents and manufacturing facility" of Technomed's parent in France (Technomed International SA), which had filed for bankruptcy in September 1993, according to EDAP. The company says Technomed will no longer be doing business in the U.S. A newly formed EDAP Technomed group will provide "continued sales, service and technical expertise" for Sonolith and Pulsolith customers. EDAP says it has completed 95% of a premarket approval application for the Prostatron for the treatment of benign prostrate hyperplasia and plans to submit the PMA in January 1995



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts